Amgen to slash price of cholesterol drug Repatha by 60%
October 24, 2019 at 15:36 PM EDT
Amgen is attempting to make the medicine more affordable to patients and kick-start sales.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.